SCHEMBL8260

SCHEMBL8260

Cc1cccc2c1cc(C(=O)O)n2O

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DAO P14920 2/20 0.59
SLC9A1 P19634 1/20 0.49
LDHA P00338 5/20 0.48
MCL1 Q07820 1/20 0.45
PLA2G10 O15496 1/20 0.43
F10 P00742 1/20 0.41
HDAC4 P56524 1/20 0.41
HDAC1 Q13547 1/20 0.41
HDAC7 Q8WUI4 1/20 0.41
HDAC8 Q9BY41 1/20 0.41
HDAC6 Q9UBN7 1/20 0.41
HDAC9 Q9UKV0 1/20 0.41
HDAC5 Q9UQL6 1/20 0.41
ALDH1A1 P00352 4/20 0.40
TSHR P16473 1/20 0.40
HPGD P15428 3/20 0.40
FABP4 P15090 1/20 0.40
GAA P10253 1/20 0.40
MAPT P10636 1/20 0.40
NPC1 O15118 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2276306 0.83 SLC9A1 (0.64) DAOSLC9A1MCL1PLA2G10F10
SCHEMBL28229955 0.81 SLC9A1 (0.48) DAOSLC9A1MCL1PLA2G10F10
SCHEMBL14118716 0.79 DAO (0.54) DAOLDHAMCL1HDAC4HDAC1
SCHEMBL8261 0.79 CCR2 (0.56) DAOLDHAMCL1HDAC4HDAC1
SCHEMBL8055 0.79 DAO (0.54) DAOLDHAMCL1HDAC4HDAC1
SCHEMBL10755572 0.79 ALDH1A1 (0.64) DAOSLC9A1MCL1PLA2G10ALDH1A1
SCHEMBL699819 0.79 GPR35 (0.53) SLC9A1PLA2G10F10ALDH1A1HPGD
SCHEMBL8014 0.77 DAO (0.56) DAOLDHAMCL1HDAC4HDAC1
SCHEMBL8347 0.76 LDHA (0.66) DAOSLC9A1LDHAHDAC4HDAC1
SCHEMBL38660820 0.75 F10 (0.43) DAOSLC9A1MCL1PLA2G10F10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120309794-A1 COMPOUNDS INHIBITORS OF ENZYME LACTATE DEHYDROGENASE (LDH) AND PHARMACEUTICAL COMPOSITIONS CONTAINING THESE COMPOUNDS UNIVERSITÀ DI PISA (IT) 2012-12-06 US disclosed
EP-2499114-A1 COMPOUNDS INHIBITORS OF ENZYME LACTATE DEHYDROGENASE (LDH) AND PHARMACEUTICAL COMPOSITIONS CONTAINING THESE COMPOUNDS Universita Di Pisa (IT) 2012-09-19 EP disclosed
WO-2011054525-A1 COMPOUNDS INHIBITORS OF ENZYME LACTATE DEHYDROGENASE (LDH) AND PHARMACEUTICAL COMPOSITIONS CONTAINING THESE COMPOUNDS UNIVERSITA' DI PISA (IT) 2011-05-12 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120309794-A1 COMPOUNDS INHIBITORS OF ENZYME LACTATE DEHYDROGENASE (LDH) AND PHARMACEUTICAL COMPOSITIONS CONTAINING THESE COMPOUNDS LDHA, LDHB, DLD DAO 565/4885SLC9A1 1470/4885LDHA 1/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.